Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.

Pipe SW, Leebeek FWG, Recht M, Key NS, Castaman G, Miesbach W, Lattimore S, Peerlinck K, Van der Valk P, Coppens M, Kampmann P, Meijer K, O'Connell N, Pasi KJ, Hart DP, Kazmi R, Astermark J, Hermans CRJR, Klamroth R, Lemons R, Visweshwar N, von Drygalski A, Young G, Crary SE, Escobar M, Gomez E, Kruse-Jarres R, Quon DV, Symington E, Wang M, Wheeler AP, Gut R, Liu YP, Dolmetsch RE, Cooper DL, Li Y, Goldstein B, Monahan PE

Open source

DOI
10.1056/nejmoa2211644
Published
2023 Feb 23
Container
The New England journal of medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2211644,
  title = {Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.},
  author = {Pipe SW and Leebeek FWG and Recht M and Key NS and Castaman G and Miesbach W and Lattimore S and Peerlinck K and Van der Valk P and Coppens M and Kampmann P and Meijer K and O'Connell N and Pasi KJ and Hart DP and Kazmi R and Astermark J and Hermans CRJR and Klamroth R and Lemons R and Visweshwar N and von Drygalski A and Young G and Crary SE and Escobar M and Gomez E and Kruse-Jarres R and Quon DV and Symington E and Wang M and Wheeler AP and Gut R and Liu YP and Dolmetsch RE and Cooper DL and Li Y and Goldstein B and Monahan PE},
  year = {2023},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2211644},
  url = {https://doi.org/10.1056/nejmoa2211644}
}

RIS

TY  - JOUR
TI  - Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
AU  - Pipe SW
AU  - Leebeek FWG
AU  - Recht M
AU  - Key NS
AU  - Castaman G
AU  - Miesbach W
AU  - Lattimore S
AU  - Peerlinck K
AU  - Van der Valk P
AU  - Coppens M
AU  - Kampmann P
AU  - Meijer K
AU  - O'Connell N
AU  - Pasi KJ
AU  - Hart DP
AU  - Kazmi R
AU  - Astermark J
AU  - Hermans CRJR
AU  - Klamroth R
AU  - Lemons R
AU  - Visweshwar N
AU  - von Drygalski A
AU  - Young G
AU  - Crary SE
AU  - Escobar M
AU  - Gomez E
AU  - Kruse-Jarres R
AU  - Quon DV
AU  - Symington E
AU  - Wang M
AU  - Wheeler AP
AU  - Gut R
AU  - Liu YP
AU  - Dolmetsch RE
AU  - Cooper DL
AU  - Li Y
AU  - Goldstein B
AU  - Monahan PE
PY  - 2023
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2211644
UR  - https://doi.org/10.1056/nejmoa2211644
ER  - 

APA

SW, P., FWG, L., M, R., NS, K., G, C., W, M., S, L., K, P., P, V. D. V., M, C., P, K., K, M., N, O., KJ, P., DP, H., R, K., J, A., CRJR, H., R, K., R, L., N, V., A, V. D., G, Y., SE, C., M, E., E, G., R, K., DV, Q., E, S., M, W., AP, W., R, G., YP, L., RE, D., DL, C., Y, L., B, G., & PE, M. (2023). Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2211644

Source records